← Leaderboards
Michael V Drake
University Of California San Francisco
$708,380
Attributed
$708,380
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$708,380 · 1
By mechanism
U10$708,380 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- David Krizaj$11,313,886
- David W Sretavan$7,981,632
- Alan S Verkman$35,167,321
- Jeanette Hyer$2,123,487
- Joan M O'Brien$20,603,895
Others in their field
Top investigators on “Beta Antiadrenergic Agent”
- Christopher M O'Connor · Duke University$18,508,673
- Michael A Kass · Washington University$9,081,282
- Bruce M Psaty · University Of Washington$5,047,845
- Kenneth Allen Holroyd · Ohio University Athens$2,665,090
- Jeffrey H Silverstein · Mount Sinai School Of Medicine Of Nyu$2,655,974
- Susan Heckbert · University Of Washington$2,562,214
Research focus
Beta Antiadrenergic AgentStatistics /BiometryMioticDisease /Disorder Proneness /RiskDrug Adverse EffectDosageDrug Administration RoutesEarly DiagnosisEpinephrineEye Disorder ChemotherapyEye Fundus PhotographyEye PharmacologyGlaucomaGlaucoma TestHuman SubjectHuman Therapy EvaluationIntraocular PressureLongitudinal Human StudyMass ScreeningMedical ComplicationOptic DiskPilocarpinePrognosisTherapy Compliance
Grant awards (6)
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$105,024
U10 · FY2005 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$102,657
U10 · FY2004 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$140,980
U10 · FY2003 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$137,323
U10 · FY2002 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$119,068
U10 · FY2001 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$103,328
U10 · FY2000 · EY